No. 1Space
Webb finds a dense, early galaxy cluster that models struggle to explain
Astronomers using the James Webb Space Telescope report that a galaxy cluster called XLSSC 122 packs an unusual amount of mass into its center. It sits about 10.4 billion light-years away, in the era known as cosmic noon, when clusters were still assembling. Webb also saw curved arcs of light around it, making it the most distant cluster known to show strong gravitational lensing. Because most of that lensing comes from dark matter, the arcs let researchers map mass they cannot see. Three papers describe the work. One says the cluster is still merging, and another reports the earliest known intracluster light. The lead author says the mass concentration disagrees with model predictions. This is one cluster, so the tension is a clue rather than a verdict.
No. 2Climate
El Niño hits record readings weeks before its expected December peak
The current El Niño keeps setting records. Australia's Bureau of Meteorology says weekly average sea-surface temperatures in the central Pacific are the highest on record. Parts of the tropical Pacific have also topped 30C for the first time. Forecasters now use an index that strips out background ocean warming, and on that measure the readings exceed December 2015. One caution: the bureau's weekly data only goes back to 2008. The World Meteorological Organization says there is no evidence that climate change makes El Niño stronger or more frequent. El Niño does add heat to the atmosphere, though, and 2026 is expected to be among the warmest years on record, with high temperatures likely into 2027. Forecasts from European and US agencies point to a December peak.
Why it mattersYou can expect hotter global temperatures and more weather disruption, including drought, flooding and food-security worries, as the event peaks.
Full story at BBC News →No. 3Health policy
Many FDA panel patient reps have ties to industry-funded advocacy groups
A new analysis in Health Affairs Scholar looked at FDA advisory committee meetings over a 20-year period. Nearly 40% included a patient or consumer representative with active ties to an advocacy group funded by drug companies. For several committees, that share passed 50%. In more than one in 10 meetings, a representative was linked to an organization funded by the maker of the drug under review. Most of these ties were not disclosed at the meetings. The authors note that the FDA has well-established conflict-of-interest rules for its scientific members, but its policies for patient and consumer representatives are less developed. Our source for this story is only a short excerpt, so we cannot say whether these ties changed any votes.
Why it mattersYou may want to know whose voices shape the review of medicines, and how openly any financial links are shown.
Full story at STAT →No. 4Biology
A DNA "typewriter" lets scientists trace a mouse embryo's cell lineage
Researchers at the University of Washington and Dartmouth built a family tree of cells in a developing mouse. They used a tool called DNA Typewriter, which writes a record into a cell's DNA, one character per division, in strict order. The record covered the first 13.5 days of development, and the work appeared in Science on October 8. The team started with 100 fertilized eggs, and 10 embryos were available for study. Most of the detailed analysis focused on the one embryo where the recording worked best. One of the first two cells left more descendants than the other, but both produced similar mixes of cell types. Blood and retina cells committed to their roles early, while the skin's outer layer committed later. The authors hope this will eventually inform research on birth defects and cancer.